Vanguard Group’s Vivos Therapeutics VVOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $135K | Hold |
42,634
| – | – | ﹤0.01% | 4120 |
|
|
2025
Q1 | $122K | Buy |
42,634
+32,055
| +303% | +$91.4K | ﹤0.01% | 4118 |
|
|
2024
Q4 | $45.4K | Hold |
10,579
| – | – | ﹤0.01% | 4221 |
|
|
2024
Q3 | $27.6K | Hold |
10,579
| – | – | ﹤0.01% | 4279 |
|
|
2024
Q2 | $23.5K | Hold |
10,579
| – | – | ﹤0.01% | 4350 |
|
|
2024
Q1 | $51.1K | Hold |
10,579
| – | – | ﹤0.01% | 4317 |
|
|
2023
Q4 | $132K | Sell |
10,579
-604,436
| -98% | -$7.52M | ﹤0.01% | 4273 |
|
|
2023
Q3 | $118K | Sell |
615,015
-99,091
| -14% | -$19K | ﹤0.01% | 4328 |
|
|
2023
Q2 | $364K | Sell |
714,106
-5,061
| -0.7% | -$2.58K | ﹤0.01% | 4198 |
|
|
2023
Q1 | $245K | Sell |
719,167
-12,675
| -2% | -$4.32K | ﹤0.01% | 4291 |
|
|
2022
Q4 | $294K | Buy |
731,842
+464
| +0.1% | +$187 | ﹤0.01% | 4227 |
|
|
2022
Q3 | $475K | Buy |
731,378
+36,327
| +5% | +$23.6K | ﹤0.01% | 4227 |
|
|
2022
Q2 | $897K | Hold |
695,051
| – | – | ﹤0.01% | 4124 |
|
|
2022
Q1 | $1.86M | Buy |
695,051
+31,798
| +5% | +$85.2K | ﹤0.01% | 3989 |
|
|
2021
Q4 | $1.49M | Buy |
663,253
+46,002
| +7% | +$103K | ﹤0.01% | 4140 |
|
|
2021
Q3 | $2.49M | Buy |
617,251
+233,360
| +61% | +$943K | ﹤0.01% | 3991 |
|
|
2021
Q2 | $1.9M | Buy |
+383,891
| New | +$1.9M | ﹤0.01% | 3975 |
|